Barrett & Company’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-85
Closed -$1.24K 601
2024
Q1
$1.24K Hold
85
﹤0.01% 570
2023
Q4
$1.18K Buy
85
+4
+5% +$55 ﹤0.01% 561
2023
Q3
$1.11K Buy
+81
New +$1.15K ﹤0.01% 576

Other funds holding DIAX

Barrett & Company's DIAX Position: Q2 2024 in Review

Barrett & Company sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q2 2024, closing a stake of 85 shares — an estimated $1.24K sold.

Barrett & Company first reported a position in DIAX in Q3 2023 and held it in 3 quarters. The position peaked at $1.24K in Q1 2024. 86 funds tracked by Wall St. Rank hold DIAX as of Q2 2024.

  • Barrett & Company reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q2 2024 after selling out during the quarter.
  • Barrett & Company sold 85 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q2 2024, an estimated $1.24K.
  • Barrett & Company first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q3 2023 and held it in 3 quarters.
  • Barrett & Company's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $1.24K in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q2 2024.

Based on Barrett & Company's 13F filing for Q2 2024, filed 25 Jul 2024.